UBS Group’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-54
| Closed | -$658 | – | 9033 |
|
|
2023
Q1 | $658 | Buy |
+54
| New | +$658 | ﹤0.01% | 7833 |
|
|
2022
Q2 | – | Sell |
-198
| Closed | -$4K | – | 10145 |
|
|
2022
Q1 | $4K | Sell |
198
-304
| -61% | -$6.14K | ﹤0.01% | 8318 |
|
|
2021
Q4 | $18K | Buy |
502
+425
| +552% | +$15.2K | ﹤0.01% | 6906 |
|
|
2021
Q3 | $6K | Sell |
77
-144
| -65% | -$11.2K | ﹤0.01% | 7329 |
|
|
2021
Q2 | $31K | Buy |
221
+103
| +87% | +$14.4K | ﹤0.01% | 5827 |
|
|
2021
Q1 | $34K | Buy |
118
+78
| +195% | +$22.5K | ﹤0.01% | 5901 |
|
|
2020
Q4 | $25K | Buy |
+40
| New | +$25K | ﹤0.01% | 5781 |
|